trial

Insight in Persons Presenting Schizophrenia or Related Troubles During Hospitalization in Psychiatry

NCTId NCT01611337
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 205 (actual)
Sponsored by Centre Hospitalier Esquirol
Primary completion 2017-07
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
205 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2012-06
Primary completion
2017-07
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
insight variation measure

Sponsors

Centre Hospitalier EsquirolLead Sponsor

Investigators

1
Danielle Bourlot, MDPrincipal Investigator

Sites

2 total
Limoges, FranceSaint-Vaury, France

Facts & assertions

4 sourced
Enrollment
205
Phase
NA
Primary Completion Date
2017-07
Status
COMPLETED
relationships
The graph out of here
drug
insight variation measure
drug
lead_sponsor
Centre Hospitalier Esquirol
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Danielle Bourlot, MD
person